APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valacyclovir Oral

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Valacyclovir Oral Industry Growth and Trends Forecast to 2032

20 December 2025110 pages

Choose your research edition.

Industry ResearchValacyclovir Oral Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Valacyclovir Oral Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Valacyclovir Oral Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valacyclovir Oral Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Valacyclovir Oral Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Valacyclovir Oral market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Valacyclovir Oral is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Valacyclovir Oral is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valacyclovir Oral is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valacyclovir Oral include GSK, Teva, Sun Pharmaceutical, Shandong Luoxin Pharmaceutical Group, Sandoz, Mylan, Lunan Pharmaceutical, Zydus Pharmaceuticals and Wockhardt, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Valacyclovir Oral market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Valacyclovir Oral market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valacyclovir Oral market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valacyclovir Oral.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Valacyclovir Oral market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Valacyclovir Oral Market by Company

GSK

Teva

Sun Pharmaceutical

Shandong Luoxin Pharmaceutical Group

Sandoz

Mylan

Lunan Pharmaceutical

Zydus Pharmaceuticals

Wockhardt

West-Ward Pharmaceuticals

Time Cap Labs

Tasly

Jubilant Pharma

Cipla

Aurobindo Pharma

Apotex

Valacyclovir Oral Segment by Type

1000mg Tablet

300mg Tablet

500mg Tablet

Others

Valacyclovir Oral Segment by Application

Hospital

Drug Store

Valacyclovir Oral Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valacyclovir Oral market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valacyclovir Oral and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valacyclovir Oral.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valacyclovir Oral manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Valacyclovir Oral in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1000mg Tablet Table 2. Major Company of 300mg Tablet Table 3. Major Company of 500mg Tablet Table 4. Major Company of Others Table 5. Global Valacyclovir Oral Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Valacyclovir Oral Sales by Type (2021-2026) & (W Units) Table 7. Global Valacyclovir Oral Sales Market Share in Volume by Type (2021-2026) Table 8. Global Valacyclovir Oral Sales by Type (2021-2026) & (US$ Million) Table 9. Global Valacyclovir Oral Sales Market Share in Value by Type (2021-2026) Table 10. Global Valacyclovir Oral Price by Type (2021-2026) & (US$/Unit) Table 11. Global Valacyclovir Oral Sales by Type (2027-2032) & (W Units) Table 12. Global Valacyclovir Oral Sales Market Share in Volume by Type (2027-2032) Table 13. Global Valacyclovir Oral Sales by Type (2027-2032) & (US$ Million) Table 14. Global Valacyclovir Oral Sales Market Share in Value by Type (2027-2032) Table 15. Global Valacyclovir Oral Price by Type (2027-2032) & (US$/Unit) Table 16. North America Valacyclovir Oral Sales by Type (2021-2026) & (W Units) Table 17. North America Valacyclovir Oral Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Valacyclovir Oral Sales by Type (2021-2026) & (W Units) Table 19. Europe Valacyclovir Oral Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Valacyclovir Oral Sales by Type (2021-2026) & (W Units) Table 21. Asia-Pacific Valacyclovir Oral Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Valacyclovir Oral Sales by Type (2021-2026) & (W Units) Table 23. Latin America Valacyclovir Oral Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Valacyclovir Oral Sales by Type (2021-2026) & (W Units) Table 25. Middle East and Africa Valacyclovir Oral Sales by Type (2021-2026) & (US$ Million) Table 26. Valacyclovir Oral Industry Trends Table 27. Valacyclovir Oral Industry Drivers Table 28. Valacyclovir Oral Industry Opportunities and Challenges Table 29. Valacyclovir Oral Industry Restraints Table 30. Global Valacyclovir Oral Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Valacyclovir Oral Revenue Market Share by Company (2021-2026) Table 32. Global Valacyclovir Oral Sales by Company (2021-2026) & (W Units) Table 33. Global Valacyclovir Oral Sales Share by Company (2021-2026) Table 34. Global Valacyclovir Oral Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Valacyclovir Oral Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Valacyclovir Oral Major Company Production Sites and Headquarters Table 37. Global Valacyclovir Oral Company, Product Type & Application Table 38. Global Valacyclovir Oral Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Valacyclovir Oral by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Valacyclovir Oral Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Valacyclovir Oral Sales by Region (2021-2026) & (W Units) Table 43. Global Valacyclovir Oral Sales Market Share in Volume by Region (2021-2026) Table 44. Global Valacyclovir Oral Sales by Region (2021-2026) & (US$ Million) Table 45. Global Valacyclovir Oral Sales Market Share in Value by Region (2021-2026) Table 46. Global Valacyclovir Oral Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Valacyclovir Oral Sales by Region (2027-2032) & (W Units) Table 48. Global Valacyclovir Oral Sales Market Share in Volume by Region (2027-2032) Table 49. Global Valacyclovir Oral Sales by Region (2027-2032) & (US$ Million) Table 50. Global Valacyclovir Oral Sales Market Share in Value by Region (2027-2032) Table 51. Global Valacyclovir Oral Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Valacyclovir Oral Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Valacyclovir Oral Sales by Application (2021-2026) & (W Units) Table 54. Global Valacyclovir Oral Sales Market Share in Volume by Application (2021-2026) Table 55. Global Valacyclovir Oral Sales by Application (2021-2026) & (US$ Million) Table 56. Global Valacyclovir Oral Sales Market Share in Value by Application (2021-2026) Table 57. Global Valacyclovir Oral Price by Application (2021-2026) & (US$/Unit) Table 58. Global Valacyclovir Oral Sales by Application (2027-2032) & (W Units) Table 59. Global Valacyclovir Oral Sales Market Share in Volume by Application (2027-2032) Table 60. Global Valacyclovir Oral Sales by Application (2027-2032) & (US$ Million) Table 61. Global Valacyclovir Oral Sales Market Share in Value by Application (2027-2032) Table 62. Global Valacyclovir Oral Price by Application (2027-2032) & (US$/Unit) Table 63. North America Valacyclovir Oral Sales by Application (2021-2026) & (W Units) Table 64. North America Valacyclovir Oral Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Valacyclovir Oral Sales by Application (2021-2026) & (W Units) Table 66. Europe Valacyclovir Oral Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Valacyclovir Oral Sales by Application (2021-2026) & (W Units) Table 68. Asia-Pacific Valacyclovir Oral Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Valacyclovir Oral Sales by Application (2021-2026) & (W Units) Table 70. Latin America Valacyclovir Oral Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Valacyclovir Oral Sales by Application (2021-2026) & (W Units) Table 72. Middle East and Africa Valacyclovir Oral Sales by Application (2021-2026) & (US$ Million) Table 73. GSK Company Information Table 74. GSK Business Overview Table 75. GSK Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. GSK Valacyclovir Oral Product Portfolio Table 77. GSK Recent Development Table 78. Teva Company Information Table 79. Teva Business Overview Table 80. Teva Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Teva Valacyclovir Oral Product Portfolio Table 82. Teva Recent Development Table 83. Sun Pharmaceutical Company Information Table 84. Sun Pharmaceutical Business Overview Table 85. Sun Pharmaceutical Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sun Pharmaceutical Valacyclovir Oral Product Portfolio Table 87. Sun Pharmaceutical Recent Development Table 88. Shandong Luoxin Pharmaceutical Group Company Information Table 89. Shandong Luoxin Pharmaceutical Group Business Overview Table 90. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Portfolio Table 92. Shandong Luoxin Pharmaceutical Group Recent Development Table 93. Sandoz Company Information Table 94. Sandoz Business Overview Table 95. Sandoz Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sandoz Valacyclovir Oral Product Portfolio Table 97. Sandoz Recent Development Table 98. Mylan Company Information Table 99. Mylan Business Overview Table 100. Mylan Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Mylan Valacyclovir Oral Product Portfolio Table 102. Mylan Recent Development Table 103. Lunan Pharmaceutical Company Information Table 104. Lunan Pharmaceutical Business Overview Table 105. Lunan Pharmaceutical Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Lunan Pharmaceutical Valacyclovir Oral Product Portfolio Table 107. Lunan Pharmaceutical Recent Development Table 108. Zydus Pharmaceuticals Company Information Table 109. Zydus Pharmaceuticals Business Overview Table 110. Zydus Pharmaceuticals Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Zydus Pharmaceuticals Valacyclovir Oral Product Portfolio Table 112. Zydus Pharmaceuticals Recent Development Table 113. Wockhardt Company Information Table 114. Wockhardt Business Overview Table 115. Wockhardt Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Wockhardt Valacyclovir Oral Product Portfolio Table 117. Wockhardt Recent Development Table 118. West-Ward Pharmaceuticals Company Information Table 119. West-Ward Pharmaceuticals Business Overview Table 120. West-Ward Pharmaceuticals Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. West-Ward Pharmaceuticals Valacyclovir Oral Product Portfolio Table 122. West-Ward Pharmaceuticals Recent Development Table 123. Time Cap Labs Company Information Table 124. Time Cap Labs Business Overview Table 125. Time Cap Labs Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Time Cap Labs Valacyclovir Oral Product Portfolio Table 127. Time Cap Labs Recent Development Table 128. Tasly Company Information Table 129. Tasly Business Overview Table 130. Tasly Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. Tasly Valacyclovir Oral Product Portfolio Table 132. Tasly Recent Development Table 133. Jubilant Pharma Company Information Table 134. Jubilant Pharma Business Overview Table 135. Jubilant Pharma Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Jubilant Pharma Valacyclovir Oral Product Portfolio Table 137. Jubilant Pharma Recent Development Table 138. Cipla Company Information Table 139. Cipla Business Overview Table 140. Cipla Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 141. Cipla Valacyclovir Oral Product Portfolio Table 142. Cipla Recent Development Table 143. Aurobindo Pharma Company Information Table 144. Aurobindo Pharma Business Overview Table 145. Aurobindo Pharma Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 146. Aurobindo Pharma Valacyclovir Oral Product Portfolio Table 147. Aurobindo Pharma Recent Development Table 148. Apotex Company Information Table 149. Apotex Business Overview Table 150. Apotex Valacyclovir Oral Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 151. Apotex Valacyclovir Oral Product Portfolio Table 152. Apotex Recent Development Table 153. North America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 154. North America Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 155. North America Valacyclovir Oral Sales Market Share by Country (2021-2026) Table 156. North America Valacyclovir Oral Sales Forecast by Country (2027-2032) & (W Units) Table 157. North America Valacyclovir Oral Sales Market Share Forecast by Country (2027-2032) Table 158. North America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. North America Valacyclovir Oral Market Size by Country (2021-2026) & (US$ Million) Table 160. North America Valacyclovir Oral Market Share by Country (2021-2026) Table 161. North America Valacyclovir Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. North America Valacyclovir Oral Market Share Forecast by Country (2027-2032) Table 163. Europe Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 164. Europe Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 165. Europe Valacyclovir Oral Sales Market Share by Country (2021-2026) Table 166. Europe Valacyclovir Oral Sales Forecast by Country (2027-2032) & (W Units) Table 167. Europe Valacyclovir Oral Sales Market Share Forecast by Country (2027-2032) Table 168. Europe Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Europe Valacyclovir Oral Market Size by Country (2021-2026) & (US$ Million) Table 170. Europe Valacyclovir Oral Market Share by Country (2021-2026) Table 171. Europe Valacyclovir Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Europe Valacyclovir Oral Market Share Forecast by Country (2027-2032) Table 173. Asia-Pacific Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 174. Asia-Pacific Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 175. Asia-Pacific Valacyclovir Oral Sales Market Share by Country (2021-2026) Table 176. Asia-Pacific Valacyclovir Oral Sales Forecast by Country (2027-2032) & (W Units) Table 177. Asia-Pacific Valacyclovir Oral Sales Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Valacyclovir Oral Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Valacyclovir Oral Market Share by Country (2021-2026) Table 181. Asia-Pacific Valacyclovir Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Valacyclovir Oral Market Share Forecast by Country (2027-2032) Table 183. Latin America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 184. Latin America Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 185. Latin America Valacyclovir Oral Sales Market Share by Country (2021-2026) Table 186. Latin America Valacyclovir Oral Sales Forecast by Country (2027-2032) & (W Units) Table 187. Latin America Valacyclovir Oral Sales Market Share Forecast by Country (2027-2032) Table 188. Latin America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Latin America Valacyclovir Oral Market Size by Country (2021-2026) & (US$ Million) Table 190. Latin America Valacyclovir Oral Market Share by Country (2021-2026) Table 191. Latin America Valacyclovir Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Latin America Valacyclovir Oral Market Share Forecast by Country (2027-2032) Table 193. Middle East and Africa Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 194. Middle East and Africa Valacyclovir Oral Sales by Country (2021-2026) & (W Units) Table 195. Middle East and Africa Valacyclovir Oral Sales Market Share by Country (2021-2026) Table 196. Middle East and Africa Valacyclovir Oral Sales Forecast by Country (2027-2032) & (W Units) Table 197. Middle East and Africa Valacyclovir Oral Sales Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Valacyclovir Oral Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Valacyclovir Oral Market Size by Country (2021-2026) & (US$ Million) Table 200. Middle East and Africa Valacyclovir Oral Market Share by Country (2021-2026) Table 201. Middle East and Africa Valacyclovir Oral Market Size Forecast by Country (2027-2032) & (US$ Million) Table 202. Middle East and Africa Valacyclovir Oral Market Share Forecast by Country (2027-2032) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Valacyclovir Oral Distributors List Table 206. Valacyclovir Oral Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Valacyclovir Oral Image Figure 2. Global Valacyclovir Oral Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valacyclovir Oral Market Size (2021-2032) & (US$ Million) Figure 4. Global Valacyclovir Oral Sales (2021-2032) & (W Units) Figure 5. 1000mg Tablet Image Figure 6. Global 1000mg Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 7. 300mg Tablet Image Figure 8. Global 300mg Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 9. 500mg Tablet Image Figure 10. Global 500mg Tablet Sales YoY Growth (2021-2032) & (W Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 13. Global Valacyclovir Oral Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Valacyclovir Oral Market Share by Type 2025 VS 2032 Figure 15. North America Valacyclovir Oral Sales Market Share in Volume by Type in 2025 Figure 16. North America Valacyclovir Oral Sales Market Share in Value by Type in 2025 Figure 17. Europe Valacyclovir Oral Sales Market Share in Volume by Type in 2025 Figure 18. Europe Valacyclovir Oral Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Valacyclovir Oral Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Valacyclovir Oral Sales Market Share in Value by Type in 2025 Figure 21. Latin America Valacyclovir Oral Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Valacyclovir Oral Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Valacyclovir Oral Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Valacyclovir Oral Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Valacyclovir Oral Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 29. Drug Store Image Figure 30. Global Drug Store Sales YoY Growth (2021-2032) & (W Units) Figure 31. Global Valacyclovir Oral Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Valacyclovir Oral Market Share by Application 2025 VS 2032 Figure 33. North America Valacyclovir Oral Sales Market Share in Volume by Application in 2025 Figure 34. North America Valacyclovir Oral Sales Market Share in Value by Application in 2025 Figure 35. Europe Valacyclovir Oral Sales Market Share in Volume by Application in 2025 Figure 36. Europe Valacyclovir Oral Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Valacyclovir Oral Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Valacyclovir Oral Sales Market Share in Value by Application in 2025 Figure 39. Latin America Valacyclovir Oral Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Valacyclovir Oral Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Valacyclovir Oral Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Valacyclovir Oral Sales Market Share in Value by Application in 2025 Figure 43. North America Valacyclovir Oral Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. North America Valacyclovir Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Valacyclovir Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Valacyclovir Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Valacyclovir Oral Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Europe Valacyclovir Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Valacyclovir Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Valacyclovir Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Valacyclovir Oral Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Asia-Pacific Valacyclovir Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Valacyclovir Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Valacyclovir Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Valacyclovir Oral Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Latin America Valacyclovir Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Valacyclovir Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Valacyclovir Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Valacyclovir Oral Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Middle East and Africa Valacyclovir Oral Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Valacyclovir Oral Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Valacyclovir Oral Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Valacyclovir Oral Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Valacyclovir Oral Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1000mg Tablet
  • 300mg Tablet
  • 500mg Tablet
  • Others
Applications
  • Hospital
  • Drug Store
Companies covered
  • GSK
  • Teva
  • Sun Pharmaceutical
  • Shandong Luoxin Pharmaceutical Group
  • Sandoz
  • Mylan
  • Lunan Pharmaceutical
  • Zydus Pharmaceuticals
  • Wockhardt
  • West-Ward Pharmaceuticals
  • Time Cap Labs
  • Tasly
  • Jubilant Pharma
  • Cipla
  • Aurobindo Pharma
  • Apotex

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valacyclovir Oral Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Valacyclovir Oral Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Valacyclovir Oral Market by Type
  6. 1.3.1 1000mg Tablet
  7. 1.3.2 300mg Tablet
  8. 1.3.3 500mg Tablet
  9. 1.3.4 Others
  10. 1.4 Global Valacyclovir Oral Market Size by Type
  11. 1.4.1 Global Valacyclovir Oral Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Valacyclovir Oral Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Valacyclovir Oral Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Valacyclovir Oral Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Valacyclovir Oral Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Valacyclovir Oral Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Valacyclovir Oral Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Valacyclovir Oral Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Valacyclovir Oral Industry Trends
  2. 2.2 Valacyclovir Oral Industry Drivers
  3. 2.3 Valacyclovir Oral Industry Opportunities and Challenges
  4. 2.4 Valacyclovir Oral Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Valacyclovir Oral Revenue (2021-2026)
  2. 3.2 Global Top Players by Valacyclovir Oral Sales (2021-2026)
  3. 3.3 Global Top Players by Valacyclovir Oral Price (2021-2026)
  4. 3.4 Global Valacyclovir Oral Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valacyclovir Oral Major Company Production Sites & Headquarters
  6. 3.6 Global Valacyclovir Oral Company, Product Type & Application
  7. 3.7 Global Valacyclovir Oral Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valacyclovir Oral Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valacyclovir Oral Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valacyclovir Oral Tier 1, Tier 2, and Tier 3
4 Valacyclovir Oral Regional Status and Outlook
  1. 4.1 Global Valacyclovir Oral Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Valacyclovir Oral Historic Market Size by Region
  3. 4.2.1 Global Valacyclovir Oral Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Valacyclovir Oral Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Valacyclovir Oral Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Valacyclovir Oral Forecasted Market Size by Region
  7. 4.3.1 Global Valacyclovir Oral Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Valacyclovir Oral Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Valacyclovir Oral Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valacyclovir Oral by Application
  1. 5.1 Valacyclovir Oral Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Valacyclovir Oral Market Size by Application
  5. 5.2.1 Global Valacyclovir Oral Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Valacyclovir Oral Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Valacyclovir Oral Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Valacyclovir Oral Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Valacyclovir Oral Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Valacyclovir Oral Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Valacyclovir Oral Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Valacyclovir Oral Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Valacyclovir Oral Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Valacyclovir Oral Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharmaceutical
  14. 6.3.1 Sun Pharmaceutical Company Information
  15. 6.3.2 Sun Pharmaceutical Business Overview
  16. 6.3.3 Sun Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharmaceutical Valacyclovir Oral Product Portfolio
  18. 6.3.5 Sun Pharmaceutical Recent Developments
  19. 6.4 Shandong Luoxin Pharmaceutical Group
  20. 6.4.1 Shandong Luoxin Pharmaceutical Group Company Information
  21. 6.4.2 Shandong Luoxin Pharmaceutical Group Business Overview
  22. 6.4.3 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shandong Luoxin Pharmaceutical Group Valacyclovir Oral Product Portfolio
  24. 6.4.5 Shandong Luoxin Pharmaceutical Group Recent Developments
  25. 6.5 Sandoz
  26. 6.5.1 Sandoz Company Information
  27. 6.5.2 Sandoz Business Overview
  28. 6.5.3 Sandoz Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sandoz Valacyclovir Oral Product Portfolio
  30. 6.5.5 Sandoz Recent Developments
  31. 6.6 Mylan
  32. 6.6.1 Mylan Company Information
  33. 6.6.2 Mylan Business Overview
  34. 6.6.3 Mylan Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Mylan Valacyclovir Oral Product Portfolio
  36. 6.6.5 Mylan Recent Developments
  37. 6.7 Lunan Pharmaceutical
  38. 6.7.1 Lunan Pharmaceutical Company Information
  39. 6.7.2 Lunan Pharmaceutical Business Overview
  40. 6.7.3 Lunan Pharmaceutical Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Lunan Pharmaceutical Valacyclovir Oral Product Portfolio
  42. 6.7.5 Lunan Pharmaceutical Recent Developments
  43. 6.8 Zydus Pharmaceuticals
  44. 6.8.1 Zydus Pharmaceuticals Company Information
  45. 6.8.2 Zydus Pharmaceuticals Business Overview
  46. 6.8.3 Zydus Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zydus Pharmaceuticals Valacyclovir Oral Product Portfolio
  48. 6.8.5 Zydus Pharmaceuticals Recent Developments
  49. 6.9 Wockhardt
  50. 6.9.1 Wockhardt Company Information
  51. 6.9.2 Wockhardt Business Overview
  52. 6.9.3 Wockhardt Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Wockhardt Valacyclovir Oral Product Portfolio
  54. 6.9.5 Wockhardt Recent Developments
  55. 6.10 West-Ward Pharmaceuticals
  56. 6.10.1 West-Ward Pharmaceuticals Company Information
  57. 6.10.2 West-Ward Pharmaceuticals Business Overview
  58. 6.10.3 West-Ward Pharmaceuticals Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 West-Ward Pharmaceuticals Valacyclovir Oral Product Portfolio
  60. 6.10.5 West-Ward Pharmaceuticals Recent Developments
  61. 6.11 Time Cap Labs
  62. 6.11.1 Time Cap Labs Company Information
  63. 6.11.2 Time Cap Labs Business Overview
  64. 6.11.3 Time Cap Labs Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Time Cap Labs Valacyclovir Oral Product Portfolio
  66. 6.11.5 Time Cap Labs Recent Developments
  67. 6.12 Tasly
  68. 6.12.1 Tasly Company Information
  69. 6.12.2 Tasly Business Overview
  70. 6.12.3 Tasly Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Tasly Valacyclovir Oral Product Portfolio
  72. 6.12.5 Tasly Recent Developments
  73. 6.13 Jubilant Pharma
  74. 6.13.1 Jubilant Pharma Company Information
  75. 6.13.2 Jubilant Pharma Business Overview
  76. 6.13.3 Jubilant Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jubilant Pharma Valacyclovir Oral Product Portfolio
  78. 6.13.5 Jubilant Pharma Recent Developments
  79. 6.14 Cipla
  80. 6.14.1 Cipla Company Information
  81. 6.14.2 Cipla Business Overview
  82. 6.14.3 Cipla Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Cipla Valacyclovir Oral Product Portfolio
  84. 6.14.5 Cipla Recent Developments
  85. 6.15 Aurobindo Pharma
  86. 6.15.1 Aurobindo Pharma Company Information
  87. 6.15.2 Aurobindo Pharma Business Overview
  88. 6.15.3 Aurobindo Pharma Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Aurobindo Pharma Valacyclovir Oral Product Portfolio
  90. 6.15.5 Aurobindo Pharma Recent Developments
  91. 6.16 Apotex
  92. 6.16.1 Apotex Company Information
  93. 6.16.2 Apotex Business Overview
  94. 6.16.3 Apotex Valacyclovir Oral Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Apotex Valacyclovir Oral Product Portfolio
  96. 6.16.5 Apotex Recent Developments
7 North America by Country
  1. 7.1 North America Valacyclovir Oral Sales by Country
  2. 7.1.1 North America Valacyclovir Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Valacyclovir Oral Sales by Country (2021-2026)
  4. 7.1.3 North America Valacyclovir Oral Sales Forecast by Country (2027-2032)
  5. 7.2 North America Valacyclovir Oral Market Size by Country
  6. 7.2.1 North America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Valacyclovir Oral Market Size by Country (2021-2026)
  8. 7.2.3 North America Valacyclovir Oral Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Valacyclovir Oral Sales by Country
  2. 8.1.1 Europe Valacyclovir Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Valacyclovir Oral Sales by Country (2021-2026)
  4. 8.1.3 Europe Valacyclovir Oral Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Valacyclovir Oral Market Size by Country
  6. 8.2.1 Europe Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Valacyclovir Oral Market Size by Country (2021-2026)
  8. 8.2.3 Europe Valacyclovir Oral Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Valacyclovir Oral Sales by Country
  2. 9.1.1 Asia-Pacific Valacyclovir Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Valacyclovir Oral Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Valacyclovir Oral Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Valacyclovir Oral Market Size by Country
  6. 9.2.1 Asia-Pacific Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Valacyclovir Oral Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Valacyclovir Oral Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Valacyclovir Oral Sales by Country
  2. 10.1.1 South America Valacyclovir Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Valacyclovir Oral Sales by Country (2021-2026)
  4. 10.1.3 South America Valacyclovir Oral Sales Forecast by Country (2027-2032)
  5. 10.2 South America Valacyclovir Oral Market Size by Country
  6. 10.2.1 South America Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Valacyclovir Oral Market Size by Country (2021-2026)
  8. 10.2.3 South America Valacyclovir Oral Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Valacyclovir Oral Sales by Country
  2. 11.1.1 Middle East and Africa Valacyclovir Oral Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Valacyclovir Oral Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Valacyclovir Oral Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Valacyclovir Oral Market Size by Country
  6. 11.2.1 Middle East and Africa Valacyclovir Oral Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Valacyclovir Oral Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Valacyclovir Oral Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Valacyclovir Oral Value Chain Analysis
  2. 12.1.1 Valacyclovir Oral Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Valacyclovir Oral Production Mode & Process
  7. 12.2 Valacyclovir Oral Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Valacyclovir Oral Distributors
  10. 12.2.3 Valacyclovir Oral Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst